The results of our prognostic analysis in the Kaplan-Meier Plotter database show that the up-regulation of SMC4 expression levels is significantly related to the poor prognosis of patients with sarcoma, breast cancer, liver cancer, or ovarian cancer. This evidence concerns the gene SMC4 and breast carcinoma.